Using Retained Earnings for R&D, New Businesses and Market Development
First written in FY2016. 26 of 32 entries say "Restated". Latest entry: FY2026.
133 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The company will use retained earnings to strengthen its R&D structure to meet market needs and to invest in launching new businesses and advancing market development.」
The company reiterated its policy of using retained earnings to invest in R&D, new businesses and market development. - FY2025-H1RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the current interim consolidated accounting period was ¥392 million. There were no significant changes in the content of the R&D activities during the current interim consolidated accounting period.」
The company continued its R&D activities and reported R&D expenses of ¥392 million for the current interim consolidated accounting period. It stated that there were no significant changes in the nature of its activities. - FY2024AdvancedAnnual report
「The number of employees engaged in R&D during the current consolidated fiscal year was 51, representing approximately 11.3% of total employees.」
The company specified that 51 employees were engaged in R&D, representing approximately 11.3% of total employees. Total R&D expenses amounted to ¥485 million. - FY2024-Q3RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥338 million. There were no significant changes in the content of the R&D activities during the third quarter of the current consolidated cumulative period.」
The company continued its R&D activities and recorded R&D expenses of ¥338 million for the third quarter of the cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2024-Q2RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥246 million. There were no significant changes in the content of the R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥246 million for the second quarter of the current consolidated cumulative period. There were no significant changes in the nature of its activities. - FY2024-Q1RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥116 million. There were no significant changes in the status of R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥116 million for the first quarter of the current consolidated cumulative period. It stated that there were no significant changes in the status of its activities. - FY2023ReframedAnnual report
「The company will use retained earnings to support sustainable growth and enhance shareholder value, including by strengthening its R&D structure to meet market needs, investing to advance its global expansion, and flexibly acquiring treasury shares.」
The stated uses of retained earnings have expanded from R&D, new businesses and market development to include investment in global expansion and flexible acquisitions of treasury shares, broadening the explanation of capital allocation. - FY2023-Q3RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥386 million. There were no significant changes in the content of the R&D activities during the third quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥386 million for the third quarter of the current consolidated cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2023-Q2RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥262 million. There were no significant changes in the content of the R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued its R&D activities and recorded cumulative R&D expenses of ¥262 million. It stated that there were no significant changes in the nature of its activities. - FY2023-Q1RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥137 million. There were no significant changes in the status of R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥137 million for the first quarter of the current consolidated cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2022-Q3RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥465 million. There were no significant changes in the content of the R&D activities during the third quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥465 million for the third quarter of the cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2022-Q2RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥312 million. There were no significant changes in the content of the R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued its R&D activities and recorded cumulative R&D expenses of ¥312 million. It stated that there were no significant changes in the nature of its activities. - FY2022-Q1RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥158 million. There were no significant changes in the status of R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥158 million for the first quarter of the cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2021AdvancedAnnual report
「The number of employees engaged in R&D during the current consolidated fiscal year was 44, representing approximately 10.3% of total employees.」
The company disclosed 44 employees engaged in R&D, representing approximately 10.3% of total employees, providing specific details of its R&D structure. Total R&D expenses also increased to ¥570 million from ¥510 million in the previous year. - FY2021-Q3RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the third quarter of the current consolidated cumulative period was ¥427 million. There were no significant changes in the content of the R&D activities during the third quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥427 million for the third quarter of the consolidated cumulative period. It stated that there were no significant changes in the nature of its activities. - FY2021-Q2RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the second quarter of the current consolidated cumulative period was ¥270 million. There were no significant changes in the content of the R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥270 million for the second quarter of the consolidated cumulative period. There were no significant changes in the nature of its activities. - FY2021-Q1RestatedAnnual report
「The amount of R&D activities undertaken by the Group as a whole during the first quarter of the current consolidated cumulative period was ¥157 million. There were no significant changes in the status of R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued its R&D activities and reported R&D expenses of ¥157 million for the first quarter of the consolidated cumulative period. There were no significant changes in the nature of its activities. - FY2020RestatedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥510 million, comprising ¥159 million for the Process Business, ¥64 million for the Web Business, ¥161 million for the Inspection Equipment Business and ¥124 million for the Optics Business.」
The company continued its R&D investment and recorded annual R&D expenses of ¥510 million. No significant change in policy from the previous year's ¥509 million is reported. - FY2020-Q3RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated third-quarter period was ¥376 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated third-quarter period.」
The company continued its research and development activities and reported research and development expenses of ¥376 million for the cumulative consolidated third-quarter period. There were no material changes in the activity's content. - FY2020-Q2RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated second-quarter period was ¥255 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated second-quarter period.」
The company continued to invest in research and development and reported research and development expenses of ¥255 million for the cumulative consolidated second-quarter period. There were no material changes in the activity's content. - FY2020-Q1RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated first-quarter period was ¥134 million. There were no material changes in the group's research and development activities during the cumulative consolidated first-quarter period.」
The company continued to invest in research and development and reported research and development expenses of ¥134 million for the cumulative first-quarter period. There were no material changes in the activity's content. - FY2019AdvancedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥509 million, comprising ¥230 million for the Process Business Division, ¥46 million for the Web Business Division, ¥167 million for the Inspection Equipment Business Division and ¥64 million for Other.」
The company continued its research and development activities, bringing annual research and development expenses to ¥509 million. - FY2019-Q3RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated third-quarter period was ¥382 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated third-quarter period.」
The company continued its research and development activities and reported research and development expenses of ¥382 million for the cumulative consolidated third-quarter period. There were no material changes in the activity's content. - FY2019-Q2RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated second-quarter period was ¥260 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated second-quarter period.」
The company continued its research and development activities and reported ¥260 million for the cumulative consolidated second-quarter period. There were no material changes in the activity's content. - FY2019-Q1RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated first-quarter period was ¥121 million. There were no material changes in the group's research and development activities during the cumulative consolidated first-quarter period.」
The company continued to invest in research and development and reported research and development expenses of ¥121 million for the cumulative first-quarter period. There were no material changes in the activity's content. - FY2018AdvancedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥448 million, comprising ¥84 million for the Process Business Division, ¥49 million for the Web Business Division, ¥118 million for the Inspection Equipment Business Division and ¥195 million for Other.」
The company continued to strengthen its research and development structure and invest in new businesses and market development, bringing annual research and development expenses to ¥448 million. - FY2018-Q2RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated second-quarter period was ¥228 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated second-quarter period.」
The company continued to invest in research and development and reported ¥228 million for the cumulative consolidated second-quarter period. There were no material changes in the activity's content. - FY2018-Q1RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated first-quarter period was ¥80 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated first-quarter period.」
The company continued its research and development activities and reported ¥80 million for the cumulative consolidated first-quarter period. - FY2017RestatedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥345 million, comprising ¥158 million for the Process Business Division, ¥61 million for the Web Business Division, ¥107 million for the Inspection Equipment Business Division and ¥19 million for Other.」
The company continued to strengthen its research and development structure and invest in new businesses and market development, reporting annual research and development expenses of ¥345 million. - FY2017-Q3RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated third-quarter period was ¥259 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated third-quarter period.」
The company continued its research and development activities and reported ¥259 million for the cumulative consolidated third-quarter period. There were no material changes in the activity's content. - FY2017-Q2RestatedAnnual report
「The amount of research and development activities conducted by the group as a whole during the cumulative consolidated second-quarter period was ¥172 million. There were no material changes in the content of the group's research and development activities during the cumulative consolidated second-quarter period.」
The company continued to invest in research and development and reported an amount of ¥172 million for the cumulative consolidated second-quarter period. - FY2016First statedAnnual report
「The company will use retained earnings for investment in strengthening its research and development structure to meet market needs, launching new businesses and developing markets, with a view to sustainably increasing shareholder value.」
The company plans to allocate retained earnings to investment in research and development, new businesses and market development.